ROTA-PACE: The Efficacy and Safety of a Novel Adjunctive Pacing Strategy During Rotational Atherectomy

Sponsor
Vancouver Island Health Authority (Other)
Overall Status
Recruiting
CT.gov ID
NCT05404204
Collaborator
(none)
100
1
16.9
5.9

Study Details

Study Description

Brief Summary

Coronary artery narrowings interfere with blood flow to the heart which can cause chest pain and heart attacks. Cardiologists can treat these narrowings with balloons and stents. However, some narrowings can become very calcified and hard making treatment with balloons and stents difficult. Rotational atherectomy is a tool to treat calcific coronary disease. It uses an ablative drill to break down the hardened plaques inside the coronary arteries facilitating subsequent treatment with balloons and stents. However, during this procedure patients can experience a slow heart rate which may compromise procedural safety. Cardiologists may use a temporary pacemaker that is inserted by separately accessing the heart through a large vein usually from the leg. This maintains a safe heart rate throughout the procedure. However, inserting the temporary pacemaker is associated with additional complications. We have developed and propose an alternative strategy to provide a temporary safety pacemaker during rotational atherectomy without the need for inserting an additional pacemaker.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Strategy to ROTAblate and PACE (ROTA-PACE) Study
    Actual Study Start Date :
    Feb 1, 2021
    Anticipated Primary Completion Date :
    Jul 1, 2022
    Anticipated Study Completion Date :
    Jul 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Successful ventricular pacing [At the start of the PCI procedure immediately prior to rotational atherectomy]

      Ability to obtain successful ventricular capture prior to rotational atherectomy

    2. Ventricular pacing threshold [At the start of the PCI procedure immediately prior to rotational atherectomy]

      The pacing threshold to obtain successful ventricular capture

    Secondary Outcome Measures

    1. Complications [At the end of the PCI procedure]

      (a) Coronary wire-related intractable spasm (unresponsive to vasodilator therapy); (b) coronary wire-related perforation; (c) New atrial or ventricular arrhythmia

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Age 18-90 years

    • Undergoing percutaneous coronary intervention for angina or acute coronary syndrome.

    • Calcific coronary disease requiring rotational atherectomy

    Exclusion Criteria:
    • Pre-existing pacemaker or implantable cardioverter defibrillator.

    • Mobitz II heart block or complete heart block.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Royal Jubilee Hospital Victoria British Columbia Canada V8R 1J8

    Sponsors and Collaborators

    • Vancouver Island Health Authority

    Investigators

    • Principal Investigator: Bilal Iqbal, MD PhD FRCPC, Royal Jubilee Hospital, Victoria

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Bilal Iqbal, Doctor, Vancouver Island Health Authority
    ClinicalTrials.gov Identifier:
    NCT05404204
    Other Study ID Numbers:
    • ROTA-PACE
    First Posted:
    Jun 3, 2022
    Last Update Posted:
    Jun 3, 2022
    Last Verified:
    May 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Bilal Iqbal, Doctor, Vancouver Island Health Authority
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 3, 2022